Intermittent semaglutide availability until at least June Supply issues will remain while the medicine’s sponsor ‘continues to build stable stock supplies over coming weeks and months’.
TGA warns of online semaglutide scams The medicines regulator has said scams include advertising offers being sent to GPs for distribution to patients.
Semaglutide supplies return to Australia ahead of schedule Limited quantities of the medication will be available from late next week, the TGA has said, but GPs have been asked to not prescribe it off-label.
TGA threatens illegal semaglutide promoters with jail, $1m fines Advertisers and social media influencers have been warned against publicly spruiking the drug for the purposes of weight loss.
Semaglutide unavailable in Australia until April 2023 GPs have been told not to initiate any new patients on either semaglutide or dulaglutide, which will also only have ‘limited availability’.
Diabetes medication shortage worsens There is not expected be enough dulaglutide in Australia to fill all prescriptions for type 2 diabetes patients until at least early 2023, the TGA has warned.
Practical tool aims to help GPs manage obesity Two decades’ worth of evidence has been collated into an algorithm GPs can use when managing patients with obesity.
In Practice: Business sustainability strategies An upcoming webinar will aim to help GPs who or looking to boost their income or ensure their practice runs sustainably.
Shortage of diabetes drug flagged until 2023 While semaglutide supply will be intermittent, its current availability should be ‘enough for approved use’, the manufacturer has advised.
New diabetes medication shortage will impact patient care The semaglutide shortage is having a flow on effect, with dulaglutide now also in short supply until at least the end of August.